Across CCLE and GDSC cell-line panels, response to BPTES is significantly associated with the pathway activity of multiple pathways, with BONE cell lines showing a particularly strong set of associations.
The most reproducible BPTES response-associated pathways across cancer lineages are Cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA), Negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator, and Negative regulation of Notch signaling pathway, each associated with drug response in up to 7 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, BPTES response versus Cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) pathway activity in BONE (Pearson r = 0.33).